-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Disc Medicine, Raises Price Target to $114

Benzinga·11/10/2025 16:24:09
Listen to the news
Truist Securities analyst Danielle Brill maintains Disc Medicine (NASDAQ:IRON) with a Buy and raises the price target from $86 to $114.